TFX05-01

· Zhejiang Yangli Pharmaceutical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TFX05-01, covering 2023-03-16 to 2023-03-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TFX05-01 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]